Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

Recruiting now

Conditions studied: Obstructive Hypertrophic Cardiomyopathy

In brief

This real-world study will assess changes in health status among participants with symptomatic obstructive hypertrophic cardiomyopathy who are treated with mavacamten in the real world.

Key facts

Study ID
NCT06551129
Run by
Bristol-Myers Squibb
People needed
118
Starts
2024-05-10
Expected to finish
2027-06-30
Last updated by the study team
2024-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.